Shanda Asset Management Holdings LTD Cure Vac N.V. Call Options Transaction History

Shanda Asset Management Holdings LTD

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 14, 2022	SELL	$33.72 - $48.22 $2.06 Million - $2.95 Million	-61,100 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$49.26 - $74.5 $3.51 Million - $5.3 Million	-71,200 Reduced 53.82%	61,100 $3.34 Million
Q2 2021 Aug 16, 2021	BUY	$56.91 - $127.53 $7.53 Million - $16.9 Million	132,300 New	132,300 $9.72 Million

12.3M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $514M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Shanda Asset Management Holdings LTD, based on Form 13F filings with the SEC.

Stay updated on Shanda Asset Management Holdings LTD with notifications on news.